Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma.
Saved in:
| Title: | Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma. |
|---|---|
| Authors: | Navone SE; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy., Marfia G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Health Sciences, Milan, Italy., Guarnaccia L; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy., Rizzaro M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy., Fiore G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy., Campanella R; Andremacon Srl, Milan, Italy., Gaudino C; Azienda Ospedaliero Universitaria Policlinico Umberto I, Department of Neuroradiology, Rome, Italy., Santini D; Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Rome, Italy.; Azienda Ospedaliero Universitaria Policlinico Umberto I, Division of Oncology, Rome, Italy., Alotta GA; Andremacon Srl, Milan, Italy., Miozzo MR; University of Milan, Medical Genetics Unit, Department of Health Sciences, ASST Santi Paolo e Carlo, Milan, Italy., Barilla E; Andremacon Srl, Milan, Italy., Locatelli M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy., Riboni L; Andremacon Srl, Milan, Italy. l.riboni@andremacon.com. |
| Source: | Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Dec 26; Vol. 45 (1). Date of Electronic Publication: 2025 Dec 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41449467 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Navone+SE%22">Navone SE</searchLink>; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Marfia+G%22">Marfia G</searchLink>; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Health Sciences, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Guarnaccia+L%22">Guarnaccia L</searchLink>; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Rizzaro+M%22">Rizzaro M</searchLink>; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Fiore+G%22">Fiore G</searchLink>; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Campanella+R%22">Campanella R</searchLink>; Andremacon Srl, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Gaudino+C%22">Gaudino C</searchLink>; Azienda Ospedaliero Universitaria Policlinico Umberto I, Department of Neuroradiology, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Santini+D%22">Santini D</searchLink>; Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Rome, Italy.; Azienda Ospedaliero Universitaria Policlinico Umberto I, Division of Oncology, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Alotta+GA%22">Alotta GA</searchLink>; Andremacon Srl, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Miozzo+MR%22">Miozzo MR</searchLink>; University of Milan, Medical Genetics Unit, Department of Health Sciences, ASST Santi Paolo e Carlo, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Barilla+E%22">Barilla E</searchLink>; Andremacon Srl, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Locatelli+M%22">Locatelli M</searchLink>; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Riboni+L%22">Riboni L</searchLink>; Andremacon Srl, Milan, Italy. l.riboni@andremacon.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228308647%22">Journal of experimental & clinical cancer research : CR</searchLink> [J Exp Clin Cancer Res] 2025 Dec 26; Vol. 45 (1). <i>Date of Electronic Publication: </i>2025 Dec 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8308647 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-9966 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203929078%22">03929078 </searchLink><i>NLM ISO Abbreviation: </i>J Exp Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41449467 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13046-025-03620-3 Languages: – Code: eng Text: English Titles: – TitleFull: Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Navone SE – PersonEntity: Name: NameFull: Marfia G – PersonEntity: Name: NameFull: Guarnaccia L – PersonEntity: Name: NameFull: Rizzaro M – PersonEntity: Name: NameFull: Fiore G – PersonEntity: Name: NameFull: Campanella R – PersonEntity: Name: NameFull: Gaudino C – PersonEntity: Name: NameFull: Santini D – PersonEntity: Name: NameFull: Alotta GA – PersonEntity: Name: NameFull: Miozzo MR – PersonEntity: Name: NameFull: Barilla E – PersonEntity: Name: NameFull: Locatelli M – PersonEntity: Name: NameFull: Riboni L IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 12 Text: 2025 Dec 26 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1756-9966 Numbering: – Type: volume Value: 45 – Type: issue Value: 1 Titles: – TitleFull: Journal of experimental & clinical cancer research : CR Type: main |
| ResultId | 1 |